Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSBR | CNTX | VRCA | ||
| Company | Champions Oncolog | Context Therapeutics Inc | Verrica Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.12 | 1.0400 | 8.40 | ||
| High | 6.25 | 1.0700 | 9.78 | ||
| Low | 6.04 | 1.0300 | 7.80 | ||
| Latest | 6.04 | 1.0500 | 8.81 | ||
| Change | -0.06 | +0.0200 | +0.39 | ||
| % Change | -0.98% | +1.94% | +4.63% | ||
| Volume | 15,600 | 163,000 | 318,000 | ||
| 20-Day Average Volume | 10,045 | 386,835 | 381,490 | ||
| Previous Close | 6.10 | 1.0300 | 8.42 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.56 | 1.1225 | 5.38 | ||
| 20-Day Raw Stochastic | 7.48% | 19.64% | 84.35% | ||
| 20-Day Relative Strength | 37.90 | 45.73 | 68.78 | ||
| Weighted Alpha | +7.66 | -28.00 | -58.84 | ||
| Today's Opinion | 100% Sell | 40% Buy | 24% Buy | ||
| Previous Opinion | 88% Sell | 40% Buy | 8% Buy | ||
| Last Month's Opinion | 40% Sell | 80% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.65% since 11/28/25 | -6.25% since 11/28/25 | -3.19% since 11/28/25 | ||
| Low | 5.96 on 12/03/25 | 1.0000 on 12/04/25 | 6.26 on 12/02/25 | ||
| High | 6.57 on 12/01/25 | 1.1600 on 12/01/25 | 9.78 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | -11.18% since 11/05/25 | -7.08% since 11/05/25 | +155.36% since 11/05/25 | ||
| Low | 5.96 on 12/03/25 | 0.9999 on 11/21/25 | 3.36 on 11/07/25 | ||
| High | 7.03 on 11/12/25 | 1.2550 on 11/20/25 | 9.82 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | -11.70% since 09/05/25 | +27.99% since 09/05/25 | +72.58% since 09/05/25 | ||
| Low | 5.96 on 12/03/25 | 0.8100 on 09/12/25 | 3.28 on 11/04/25 | ||
| High | 8.74 on 09/15/25 | 1.5500 on 10/10/25 | 9.82 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | -7.08% since 06/05/25 | +90.36% since 06/05/25 | +50.99% since 06/05/25 | ||
| Low | 5.85 on 08/01/25 | 0.5501 on 06/06/25 | 3.28 on 11/04/25 | ||
| High | 9.63 on 07/09/25 | 1.5500 on 10/10/25 | 9.82 on 11/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 84,040 | 94,635 | 79,906 | ||
| Shares Outstanding, K | 13,777 | 91,879 | 9,490 | ||
| Annual Sales | 56,940,000 | 0 | 7,570,000 | ||
| Annual Net Income | 4,700,000 | -26,730,000 | -76,580,000 | ||
| Last Quarter Sales | 14,000,000 | 0 | 14,340,000 | ||
| Last Quarter Net Income | -440,000 | -9,690,000 | -270,000 | ||
| 60-Month Beta | 0.35 | 1.94 | 1.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 09/15/25 | -0.10 on 11/05/25 | 0.13 on 11/14/25 | ||
| Latest Earnings Date | 12/10/25 | 11/05/25 | 11/17/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 29.95 | 0.00 | 0.00 | ||